<MedlineCitation Status="Completed">
<MedlineID>10011559</MedlineID>
<PMID>420914</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0306-042X</ISSN>
<JournalIssue>
<Volume>6</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1979</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>A selected ion monitoring assay for primaquine in plasma and urine.</ArticleTitle>
<Pagination>
<MedlinePgn>109-12</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The antimalarial drug primaquine was analysed in plasma and urine by gas chromatography mass spectrometry, using a deuterated internal standard. After freeze-drying and extraction with trichloroethylene the sample plus internal standard was reacted with Tri Sil TBT (a 3:3:2 by volume mixture of trimethylsilylimidazole, N,O,-bis-(trimethylsilylacetamide and trimethylchlorosilane) and an aliquot injected into the gas chromatograph mass spectrometer. The gas chromatographic effluent was monitored at m/z 403 and m/z 406, the molecular ions of the bis-TMS ethers of primaquine and 6-trideuteromethoxy primaquine. Calibration curves were prepared from standards made up in plasma and urine. Data from the analysis of plasma and urine samples from a volunteer who ingested the equivalent of 45 mg primaquine are presented.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Greaves</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author>
<LastName>Price-Evans</LastName>
<ForeName>D A</ForeName>
<Initials>DA</Initials>
</Author>
<Author>
<LastName>Gilles</LastName>
<ForeName>H M</ForeName>
<Initials>HM</Initials>
</Author>
<Author>
<LastName>Baty</LastName>
<ForeName>J D</ForeName>
<Initials>JD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>ENGLAND</Country>
<MedlineTA>Biomed Mass Spectrom</MedlineTA>
<NlmUniqueID>0430246</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ions</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>90-34-6</RegistryNumber>
<NameOfSubstance>Primaquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Chromatography, Gas</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Ions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Primaquine</DescriptorName>
<QualifierName>analogs &#38; derivatives</QualifierName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
<QualifierName>blood</QualifierName>
<QualifierName>urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Spectrum Analysis, Mass</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
